Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Comp Neurol ; 425(1): 130-8, 2000 Sep 11.
Article in English | MEDLINE | ID: mdl-10940947

ABSTRACT

Alteration of serotonin (5-HT) levels influences developing thalamocortical afferents (TCAs) in primary somatosensory cortex (SI) of rats and mice. The 5-HT(1B) receptor, present on TCAs during the first postnatal week, may be involved in these effects. The present study asked whether administration of 5-nonyloxytriptamine (NNT), a selective 5-HT(1B) receptor agonist, affects TCA organization in rat SI. Littermates were injected five times daily (5x/day), with either 0.1 mg/kg NNT or vehicle from birth to postnatal day 6 (P-6). Animals were killed on P-6, and their brains were processed for high-performance liquid chromatography (HPLC), cytochrome oxidase (CO) histochemistry, cresyl violet, or demonstration of TCAs by placement of 1,1'-dioctadecyl-3,3,3'' 3'-tetra-methylindocarbocyanine perchlorate (Di-I) on thalamocortical radiations. At P-6, NNT treatment decreased 5-HT levels slightly compared with controls, although this difference was not statistically significant. In NNT-treated rats, the Di-I-labeled vibrissae-related pattern showed a range of effects, from fusion of patches related to mystacial vibrissae in treated animals to a less distinct vibrissae-related pattern in SI barrelfield compared with controls. Staining for CO and Nissl stain in layer IV of SI showed a similar range of abnormalities. These results indicate that the agonist action of NNT at the 5-HT(1B) receptor causes TCA disorganization in rat barrel field cortex in the absence of elevated 5-HT.


Subject(s)
Neurons, Afferent/physiology , Rats/physiology , Receptors, Serotonin/physiology , Somatosensory Cortex/cytology , Thalamus/cytology , Animals , Animals, Newborn , Antihypertensive Agents/pharmacology , Brain Chemistry/drug effects , Neurons, Afferent/chemistry , Organ Size , Receptor, Serotonin, 5-HT1B , Serotonin/analysis , Somatosensory Cortex/growth & development , Somatosensory Cortex/physiology , Thalamus/growth & development , Thalamus/physiology , Tocopherols , Vitamin E/analogs & derivatives , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...